NTP
vs
D
DAX Index
NTP
Over the past 12 months, NTP has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +4% growth.
Stocks Performance
NTP vs DAX Index
Performance Gap
NTP vs DAX Index
Performance By Year
NTP vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Abliva AB
Glance View
Abliva AB is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of primary mitochondrial diseases. The company is headquartered in Lund, Skane. The company went IPO on 2008-10-03. The firm focuses on the development of novel treatments for primary mitochondrial diseases.